{"id":231552,"date":"2026-09-04T13:37:18","date_gmt":"2026-09-04T08:07:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231552"},"modified":"2026-09-04T13:37:20","modified_gmt":"2026-09-04T08:07:20","slug":"is-sanofi-consumer-healthcare-india-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-sanofi-consumer-healthcare-india-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Sanofi Consumer Healthcare India a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Sanofi Consumer Healthcare India share price around Rs 4,184. 21.9% below 52-week high of Rs 5,357. Q1 FY27 revenue Rs 236 crore, up 6.7% YoY. PAT Rs 69 crore, up 13.3%. PE 36x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Sanofi Consumer Healthcare India’s Q1 FY27 results were broadly steady, with revenue at Rs 236 crore and PAT at Rs 69 crore. The Sanofi Consumer Healthcare India share price near Rs 4,184 has not moved sharply on this print, and investors asking whether Sanofi Consumer Healthcare India is a good buy should look at the underlying margin trend rather than the headline numbers alone.<\/p>\n<\/div>\n

The Sanofi Consumer Healthcare India share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Sanofi Consumer Healthcare India is the consumer healthcare business demerged from Sanofi India, focused on OTC and wellness brands, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 236 crore, up 6.7% year on year, while profit after tax came in at Rs 69 crore, up 13.3% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Sanofi Consumer Healthcare India share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Sanofi Consumer Healthcare India share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n